RE:RE:RE:Briacell dropping 30% after FASTTRACK Entirely agree - as do professional analysts - that we should be well over a dollar but can’t blame fellow shareholders the effects of the Covid pandemic or the Trial Clinics for the fact that we aren’t.
The gap between where the share is priced - i.e. the perception of the market - and where we all believe it should be is solely down to Management and inadequate presentation of the value of the Company`s IP.